{"id":21068,"date":"2026-07-31T10:33:43","date_gmt":"2026-07-31T10:33:43","guid":{"rendered":"https:\/\/woncaeurope2026.org\/sessions\/blue-sclerae-and-joint-hypermobility-in-infancy-a-primary-care-diagnostic-pathway-and-family-evaluation-approach\/"},"modified":"2026-07-31T10:33:43","modified_gmt":"2026-07-31T10:33:43","slug":"blue-sclerae-and-joint-hypermobility-in-infancy-a-primary-care-diagnostic-pathway-and-family-evaluation-approach","status":"publish","type":"wsa_session","link":"https:\/\/woncaeurope2026.org\/fr\/sessions\/blue-sclerae-and-joint-hypermobility-in-infancy-a-primary-care-diagnostic-pathway-and-family-evaluation-approach\/","title":{"rendered":"Blue sclerae and joint hypermobility in infancy: A primary care diagnostic pathway and family evaluation approach"},"content":{"rendered":"<p>Blue sclerae in infants may represent a benign variant or signal underlying connective tissue disease. Family physicians are often the first to detect these findings and must differentiate constitucional causes from heritable disorders such as osteogenesis imperfecta (OI) or Ehlers-Danlos syndrome (EDS).<\/p>\n","protected":false},"template":"","class_list":["post-21068","wsa_session","type-wsa_session","status-publish","hentry","description-off"],"_links":{"self":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/wsa_session\/21068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/wsa_session"}],"about":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/types\/wsa_session"}],"wp:attachment":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/media?parent=21068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}